Literature DB >> 27571742

Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.

Maria D Fan1, Lindsay F Kramzer2, Sharon L Hillier1,2, Judy C Chang1,2, Leslie A Meyn2, Lisa C Rohan3,4,5.   

Abstract

Unprotected heterosexual intercourse is the leading cause of HIV acquisition in women. Due to the complex nature of correct and consistent condom use by both men and women, developing alternative female-controlled HIV prevention options is a global health priority. Vaginal films containing antiretroviral drugs are a potential delivery system for the prevention of HIV acquisition through sexual contact. In this study, we explored women's preferences regarding physical characteristics of microbicide vaginal films through questionnaires and focus groups. Eighty-four sexually active, ethnically diverse women 18-30 years of age from Pittsburgh, Pennsylvania, participated in the study. Women visually and manually examined a variety of vaginal films, as well as three other vaginal products undergoing evaluation for HIV prevention: tablet, ring, and gel. Means and standard deviations or frequencies and 95 % confidence intervals were calculated for questionnaire data. Focus groups were audio-recorded, transcribed verbatim, and coded for content analysis. Women most frequently preferred vaginal films to be smooth and thin (63 %), translucent (48 %), and 2″ × 2″ square size (36 %). Driving these preferences were five major themes: ease and accuracy of use, desire for efficacy, discretion, intravaginal comfort and minimal impact, and minimizing disruption of sexual mood/activities. Women's preferences for various microbicide vaginal film physical attributes represented a balance of multiple values. In general, women desired a comfortable, efficacious, easy to use, and minimally intrusive product.

Entities:  

Keywords:  HIV prevention; Microbicide acceptability; Vaginal film; Women

Mesh:

Substances:

Year:  2016        PMID: 27571742      PMCID: PMC5332429          DOI: 10.1007/s10508-016-0816-1

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  22 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

2.  A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.

Authors:  C K Mauck; J M Baker; S P Barr; T J Abercrombie; D F Archer
Journal:  Contraception       Date:  1997-08       Impact factor: 3.375

3.  Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging.

Authors:  E Hardy; A L Jiménez; K S de Pádua; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

4.  Acceptability of two spermicides in five countries.

Authors:  E Raymond; G Alvarado; L Ledesma; S Diaz; S Bassol; E Morales; V Fernandez; G Carlos
Journal:  Contraception       Date:  1999-07       Impact factor: 3.375

5.  Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda.

Authors:  G Green; R Pool; S Harrison; G J Hart; J Wilkinson; S Nyanzi; J A Whitworth
Journal:  Soc Sci Med       Date:  2001-02       Impact factor: 4.634

6.  Users' guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  M K Giacomini; D J Cook
Journal:  JAMA       Date:  2000-07-19       Impact factor: 56.272

7.  Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.

Authors:  Annalene M Nel; Lynne B Mitchnick; Peter Risha; Lungwani Tyson Makoye Muungo; Pamela M Norick
Journal:  J Womens Health (Larchmt)       Date:  2011-07-20       Impact factor: 2.681

8.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Authors:  Jeanne M Marrazzo; Gita Ramjee; Barbra A Richardson; Kailazarid Gomez; Nyaradzo Mgodi; Gonasagrie Nair; Thesla Palanee; Clemensia Nakabiito; Ariane van der Straten; Lisa Noguchi; Craig W Hendrix; James Y Dai; Shayhana Ganesh; Baningi Mkhize; Marthinette Taljaard; Urvi M Parikh; Jeanna Piper; Benoît Mâsse; Cynthia Grossman; James Rooney; Jill L Schwartz; Heather Watts; Mark A Marzinke; Sharon L Hillier; Ian M McGowan; Z Mike Chirenje
Journal:  N Engl J Med       Date:  2015-02-05       Impact factor: 91.245

9.  Subpopulation estimates from the HIV incidence surveillance system--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-09-12       Impact factor: 17.586

10.  Perspectives related to the potential use of vaginal microbicides among drug-involved women: focus groups in three cities in the United States and Puerto Rico.

Authors:  Theresa H Mason; Susan E Foster; H Ann Finlinson; Kathleen M Morrow; Rochelle Rosen; Sandra Vining; Carol L Joanis; Theodore M Hammett; George R Seage
Journal:  AIDS Behav       Date:  2003-12
View more
  5 in total

Review 1.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

2.  Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.

Authors:  Kevin M Tyo; Hung R Vuong; Danial A Malik; Lee B Sims; Houda Alatassi; Jinghua Duan; Walter H Watson; Jill M Steinbach-Rankins
Journal:  Int J Pharm       Date:  2017-08-07       Impact factor: 5.875

3.  A mucoadhesive biodissolvable thin film for localized and rapid delivery of lidocaine for the treatment of vestibulodynia.

Authors:  Denali K Dahl; Ashlyn N Whitesell; Preetika Sharma-Huynh; Panita Maturavongsadit; Rima Janusziewicz; Ryan J Fox; Henry T Loznev; Brian Button; Allison N Schorzman; William Zamboni; Jisun Ban; Stephanie A Montgomery; Erin T Carey; S Rahima Benhabbour
Journal:  Int J Pharm       Date:  2021-11-17       Impact factor: 5.875

Review 4.  Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.

Authors:  Fernando Notario-Pérez; Roberto Ruiz-Caro; María-Dolores Veiga-Ochoa
Journal:  Drug Des Devel Ther       Date:  2017-06-15       Impact factor: 4.162

5.  Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention.

Authors:  Xin Tong; Sravan Kumar Patel; Jing Li; Dorothy Patton; Elaine Xu; Peter L Anderson; Urvi Parikh; Yvonne Sweeney; Julie Strizki; Sharon L Hillier; Lisa C Rohan
Journal:  Polymers (Basel)       Date:  2022-03-16       Impact factor: 4.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.